patent/CN-108290835-A

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108290835-A

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb9c6b40161bafe7bd55f0b4defcea04
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-96 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y207-11001 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-403 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-56
filingDate	2016-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45afa5bf13e5b8c49c6b5b1677907b11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f33115cc9abfe3b6b76b0d3a2d2b323d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_563077d61e14e1222581f66d6d8fce28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d215db0e86eec95bae03ea28458ec8e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5fc441e1e113309bb4282c083cae1be
publicationDate	2018-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	CN-108290835-A
titleOfInvention	Inhibitors of ALK and SRPK and methods of use
abstract	The present invention relates to compounds of formula (I):(I) that modulate the activity of ALK or SRPK, pharmaceutical compositions comprising the same, and methods of treating or preventing diseases in which ALK or SRPK plays a role.
priorityDate	2015-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010143664-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102015691-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104177342-A
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID49806720 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422602563

Total number of triples: 34.